The caspase 3 and caspase 3/7 activity changes between NAC/MECO and MECO were compared to validate the function of ROS in regulating caspase 3 activations of MECO-treated oral cancer cells. The gene discussed is CASP3; the disease is lip and oral cavity carcinoma.